Are you Dr. Elvin?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 42 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
200 Corporate Pl
Suite 7
Peabody, MA 01960Phone+1 978-535-3317Fax+1 978-535-2371
Summary
- Dr. Julia Elvin, MD is a board certified pathologist in Peabody, Massachusetts. She is currently licensed to practice medicine in Massachusetts, New Hampshire, and Connecticut.
Education & Training
Brigham and Womens HospitalFellowship, Selective Pathology, 2004 - 2005- Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 2002 - 2004
Baylor College of MedicineInternship, Transitional Year, 2001 - 2002- Baylor College of MedicineClass of 2001
Certifications & Licensure
NH State Medical License 2014 - Present
VT State Medical License Current
MA State Medical License 2005 - 2025
CT State Medical License 2013 - 2014
American Board of Pathology Anatomic Pathology
Publications & Presentations
PubMed
- Targetable ERBB2/HER2 Mutations in Gynecologic Malignancies: Clinicopathological, Immunohistochemical, and Molecular Correlations.Padmini A Manrai, Austin McHenry, Tong Sun, Alessandro D Santin, Elena Ratner
International Journal of Gynecological Pathology. 2025-03-01 - Clinical Utility of Liquid-based Comprehensive Genomic Profiling (CGP) in Gastrointestinal Stromal Tumors (GIST).Hiba Mechahougui, Lindsey Hildebrand, James Haberberger, Smruthy Sivakumar, Essia Saiji
Laboratory Investigation; a Journal of Technical Methods and Pathology. 2025-02-19 - Effectiveness of PARP Inhibitor Maintenance Therapy in Ovarian Cancer by BRCA1/2 and a Scar-Based HRD Signature in Real-World Practice.Debra L Richardson, Julia C F Quintanilha, Natalie Danziger, Gerald Li, Ethan Sokol
Clinical Cancer Research. 2024-10-15
Press Mentions
Comprehensive Genomic Profiling May Identify Select Subsets in Ovarian CancerAugust 11th, 2017
